These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7305463)

  • 21. [Four cases of meningeal metastasis originating from breast cancer].
    Kashiwagi S; Asano Y; Watanabe M; Morisaki T; Aomatsu N; Nakamura M; Kawajiri H; Takashima T; Onoda N; Ishikawa T; Wakasa K; Hirakawa K
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):1917-9. PubMed ID: 23267929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid biochemical markers in central nervous system tumors: a review.
    Wasserstrom WR; Schwartz MK; Fleisher M; Posner JB
    Ann Clin Lab Sci; 1981; 11(3):239-51. PubMed ID: 6166240
    [No Abstract]   [Full Text] [Related]  

  • 23. Cerebrospinal fluid and serum carcinoembryonic antigen in brain tumors.
    Batabyal SK; Ghosh B; Sengupta S; Ghosh SN; Chatterjee R
    Neoplasma; 2003; 50(5):377-9. PubMed ID: 14628092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors.
    Twijnstra A; Ongerboer de Visser BW; van Zanten AP; Hart AA; Nooyen WJ
    J Neurooncol; 1989 May; 7(1):57-63. PubMed ID: 2666594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytopathologic presentation of cerebral histiocytosis.
    Wolfson WL
    Acta Cytol; 1979; 23(5):392-8. PubMed ID: 294073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer.
    Bach F; Soletormos G; Dombernowsky P
    J Natl Cancer Inst; 1991 Jun; 83(11):779-84. PubMed ID: 2041052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinomatous meningitis in a patient with metastatic breast cancer.
    Lauby G
    Clin Lab Sci; 2001; 14(3):141-4. PubMed ID: 11517623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.
    van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Extracranial metastases from intracranial meningioma - a report of 2 cases an review of literature (author's transl)].
    Kinomoto H; Iwasaki Y; Nakagawa Y; Itoh T; Tashiro K; Abe H; Tsuru M; Higuchi M; Kaneda K
    No Shinkei Geka; 1982 Mar; 10(3):319-26. PubMed ID: 7201571
    [No Abstract]   [Full Text] [Related]  

  • 30. The application of immunocytochemistry in diagnosis of meningeal carcinomatosis in a patient with unknown primary site.
    Lee CT; Fan FS; Chen PM; Liu HC
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Nov; 50(5):429-33. PubMed ID: 1284045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis.
    Klee GG; Tallman RD; Goellner JR; Yanagihara T
    Mayo Clin Proc; 1986 Jan; 61(1):9-13. PubMed ID: 3510343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Meningeal carcinosis: early clinical manifestations of inflammatory cancer of the breast].
    Pandolfi C; Colecchia M; Bolognini G; de Fazio P; Montanari G; Pollini F; Nalli G
    Minerva Med; 1995; 86(7-8):319-22. PubMed ID: 7478076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter: Cerebral metastases and carcinoembryonic antigen in CSF.
    Snitzer LS; McKinney EC; Tejada F; Sigel MM; Rosomoff HL; Zubrod CG
    N Engl J Med; 1975 Nov; 293(21):1101. PubMed ID: 1178030
    [No Abstract]   [Full Text] [Related]  

  • 34. Cerebrospinal fluid spread of anaplastic glioma.
    Narin O; Drappatz J; Doherty LM; Wen PY; Kesari S
    J Clin Oncol; 2007 Feb; 25(5):596-7. PubMed ID: 17290068
    [No Abstract]   [Full Text] [Related]  

  • 35. Cerebrospinal fluid carcinoembryonic antigen in patients with metastatic and nonmetastatic neurological diseases.
    Twijnstra A; Nooyen WJ; van Zanten AP; Hart AA; Ongerboer de Visser BW
    Arch Neurol; 1986 Mar; 43(3):269-72. PubMed ID: 3947276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leptomeningeal carcinomatosis: review of the literature.
    Iaconetta G; Lamaida E; Rossi A; Signorelli F; Manto A; Giamundo A
    Acta Neurol (Napoli); 1994 Aug; 16(4):214-20. PubMed ID: 7856476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors.
    Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
    J Neurooncol; 1992 Feb; 12(2):111-20. PubMed ID: 1560255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Brain and leptomeningeal carcinosis in malignant melanoma. On the differential diagnosis of multiple intracerebral space-occupying lesions].
    Feltz R; Topf B; Pothe H; Endler S
    Z Arztl Fortbild (Jena); 1994 Jun; 88(5-6):455-8. PubMed ID: 8091816
    [No Abstract]   [Full Text] [Related]  

  • 39. The incidence and predictive factors for leptomeningeal spread after stereotactic radiation for breast cancer brain metastases.
    Kaidar-Person O; Deal AM; Anders CK; Ewend MG; Dees EC; Camporeale J; Ramirez J; Benbow JM; Marks LB; Zagar TM
    Breast J; 2018 May; 24(3):424-425. PubMed ID: 29251377
    [No Abstract]   [Full Text] [Related]  

  • 40. Cerebrospinal fluid biochemical markers of central nervous system metastasis.
    Schold SC; Fleisher M; Schwartz M; Posner JB
    Trans Am Neurol Assoc; 1978; 103():179-81. PubMed ID: 757052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.